Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Upper respiratory tract infections.

L Adamovic, J A Gricar, D G Cave

    Managed Care Interface
    |May 27, 1999
    PubMed
    Summary
    This summary is machine-generated.

    Routine upper respiratory infection (URI) patients typically require one office visit and incur costs primarily from physician visits. Most URI patients receive prescription drug therapy, with amoxicillin being the most common treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ischemic heart disease.

    Managed care interface·2000
    Same author

    Low back pain.

    Managed care interface·2000
    Same author

    Pediatric asthma.

    Managed care interface·2000
    Same author

    Rheumatoid arthritis.

    Managed care interface·1999
    Same author

    Gastroesophageal reflux disease.

    Managed care interface·1999
    Same author

    Pediatric otitis media.

    Managed care interface·1999
    Same journal

    Changes in hospital readmissions for diabetes-related conditions. Differences by payer.

    Managed care interface·2008
    Same journal

    Heart disease and managed care.

    Managed care interface·2008
    Same journal

    A conversation with James K. Min, MD.

    Managed care interface·2008
    Same journal

    Acute coronary syndromes.

    Managed care interface·2008
    Same journal

    Improving outcomes in cardiovascular disease.

    Managed care interface·2008
    Same journal

    The effect for oncology of the national coverage determination for erythropoiesis-stimulating agents.

    Managed care interface·2008
    See all related articles

    Area of Science:

    • Medical Economics
    • Healthcare Management
    • Infectious Disease Management

    Background:

    • Understanding the resource utilization and cost drivers for common conditions like upper respiratory infections (URIs) is crucial for healthcare system efficiency.
    • Previous studies have highlighted the economic burden of URIs, but detailed analysis of treatment patterns and associated costs for routine cases is ongoing.

    Purpose of the Study:

    • To analyze the healthcare resource utilization and cost components for routine, uncomplicated upper respiratory infection (URI) patients.
    • To identify the primary drivers of healthcare expenditure and common treatment modalities for URI patients.

    Main Methods:

    • Retrospective analysis of patient records for routine upper respiratory infection (URI) patient episodes (PTEs).
    • Quantification of office visits, diagnostic tests, laboratory services, and medical/surgical procedures utilized per PTE.

    Related Experiment Videos

  • Assessment of prescription drug therapy patterns, including the number of drug classes and specific medications prescribed.

    • Main Results:

    • Routine URI patient episodes averaged 9.6 days and involved 1.1 office visits.
    • Physician visits were the primary cost driver; 62% of URI PTEs involved prescription drug therapy, averaging 1.3 prescriptions per episode.
    • Amoxicillin was the most frequently prescribed antibiotic, with 32% receiving one drug class and 17.5% receiving two.

    Conclusions:

    • Routine URI management is characterized by low-intensity resource use, with physician visits dominating costs.
    • The majority of URI patients receive antibiotic therapy, underscoring the need for judicious antibiotic stewardship.
    • Amoxicillin remains a common first-line treatment for URIs, highlighting established prescribing practices.